Neonatal Package Study in Rural District of Pakistan
Primary Purpose
Neonatal Infections
Status
Completed
Phase
Phase 4
Locations
Pakistan
Study Type
Interventional
Intervention
Chlorhexidine
Kangaroo Mother Care
Essential Neonatal Care
Sponsored by

About this trial
This is an interventional prevention trial for Neonatal Infections focused on measuring Chlorhexidine, Kangaroo mother care, RCT
Eligibility Criteria
Inclusion Criteria:
- All healthy newborns born in the study settings will be systematically enrolled in the trial after prior consent.
Exclusion Criteria:
- Infants with congenital/birth defects,
- any localized infection on the peri umbilical region at the time of birth or application of
- any other material such as dung etc before enrollment on the cord.
Sites / Locations
- Taluka Hospital KN Shah
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
Intervention group A
Intervention group B
Control group
Arm Description
Essential Neonatal Care Kangaroo mother Care Application of 4% Chlorhexidine Education and counseling for mothers and care providers
Essential Neonatal Care Application of 4% Chlorhexidine Education and counseling for mothers and care providers
Essential Neonatal Care Education and counseling for mothers and care providers
Outcomes
Primary Outcome Measures
Reduction in the Incidence of Neonatal infections in the first 28 days of life (Clinical presence of danger signs as per the IMNCI guidelines.)
Clinical presence of danger signs as per the IMNCI guidelines.
Secondary Outcome Measures
Reduction in the Incidence of omphalitis (Redness and Swelling of umbilical stump/cord (Inflammation))
Redness and Swelling of umbilical stump/cord (Inflammation):
Failure to thrive (Weight, length and OFC appropriate for age as per WHO guidelines)
Weight, length and OFC appropriate for age as per WHO guidelines
Utilization of KMC Compliance, Frequency and duration
Compliance, Frequency and duration - hours/day
Full Information
NCT ID
NCT02279381
First Posted
October 28, 2014
Last Updated
June 8, 2016
Sponsor
Aga Khan University
Collaborators
University of Sydney, The International Federation of Red Cross and Red Crescent Societies
1. Study Identification
Unique Protocol Identification Number
NCT02279381
Brief Title
Neonatal Package Study in Rural District of Pakistan
Official Title
A Randomized Controlled Trial to Evaluate the Acceptability, Feasibility and Efficacy of the Use of a Neonatal Package to Reduce Neonatal Infection in a Rural District of Pakistan
Study Type
Interventional
2. Study Status
Record Verification Date
June 2016
Overall Recruitment Status
Completed
Study Start Date
November 2014 (undefined)
Primary Completion Date
November 2015 (Actual)
Study Completion Date
November 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aga Khan University
Collaborators
University of Sydney, The International Federation of Red Cross and Red Crescent Societies
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Neonatal mortality has been a notable health issue in Pakistan. Considering the importance of the issue and well recognized interventions the investigators are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, Kangaroo Mother Care (KMC) and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and essential neonatal care alone. The investigators anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.
Detailed Description
The global neonatal mortality burden is one of the imminent factors which derail the achievement of the MDG 4 in many developing countries including Pakistan. Four million infants infants die in their first 28 days of their lives which account for about 40% of the total under-five mortality. The burden of neonatal mortality in Pakistan is alarming as the current neonatal mortality rate (NMR) is 55 per 1000 live births, third worst in the world. The major causes of these deaths are infections, preterm births and birth asphyxia which are avoidable. Despite many initiatives the NMR remains unchanged since last decade in Pakistan.
Literature shows that low cost facility and community based interventions can reduce NMR significantly. Early neonatal care, application of chlorhexidine for cord care and Kangaroo Mother Care (KMC) have been recognized as effective intervention in reduction of neonatal morbidity and subsequently neonatal mortality in many developing countries. However these interventions have never been tested as a package and data about their combined effect is scarce both in Pakistan and developing countries.
Considering the importance of the issue and well recognized interventions we are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, KMC and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and standard neonatal care alone. We anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neonatal Infections
Keywords
Chlorhexidine, Kangaroo mother care, RCT
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1450 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention group A
Arm Type
Experimental
Arm Description
Essential Neonatal Care
Kangaroo mother Care
Application of 4% Chlorhexidine
Education and counseling for mothers and care providers
Arm Title
Intervention group B
Arm Type
Experimental
Arm Description
Essential Neonatal Care
Application of 4% Chlorhexidine
Education and counseling for mothers and care providers
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Essential Neonatal Care
Education and counseling for mothers and care providers
Intervention Type
Drug
Intervention Name(s)
Chlorhexidine
Other Intervention Name(s)
Antiseptic
Intervention Description
4% chlorhexidine will be applied to the umbilical stump from day 1 to day 10
Intervention Type
Other
Intervention Name(s)
Kangaroo Mother Care
Intervention Description
Skin to Skin Care which is Kangaroo mother care will be carried out by mother from Day 1 till the study completion
Intervention Type
Other
Intervention Name(s)
Essential Neonatal Care
Intervention Description
Essential Neonatal Care ensures delayed bathing, use of colostrum, exclusive breast feeding, skin to skin care for hypothermia, dry cord care, eye care and immunization for the newborn
Primary Outcome Measure Information:
Title
Reduction in the Incidence of Neonatal infections in the first 28 days of life (Clinical presence of danger signs as per the IMNCI guidelines.)
Description
Clinical presence of danger signs as per the IMNCI guidelines.
Time Frame
28 days post recruitment
Secondary Outcome Measure Information:
Title
Reduction in the Incidence of omphalitis (Redness and Swelling of umbilical stump/cord (Inflammation))
Description
Redness and Swelling of umbilical stump/cord (Inflammation):
Time Frame
28 days post recruitment
Title
Failure to thrive (Weight, length and OFC appropriate for age as per WHO guidelines)
Description
Weight, length and OFC appropriate for age as per WHO guidelines
Time Frame
28 days post recruitment
Title
Utilization of KMC Compliance, Frequency and duration
Description
Compliance, Frequency and duration - hours/day
Time Frame
28 days post recruitment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
28 Days
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All healthy newborns born in the study settings will be systematically enrolled in the trial after prior consent.
Exclusion Criteria:
Infants with congenital/birth defects,
any localized infection on the peri umbilical region at the time of birth or application of
any other material such as dung etc before enrollment on the cord.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Muhammad Atif Habib, MPH
Organizational Affiliation
Aga Khan University
Official's Role
Study Director
Facility Information:
Facility Name
Taluka Hospital KN Shah
City
Dadu
State/Province
Sindh
Country
Pakistan
12. IPD Sharing Statement
Learn more about this trial
Neonatal Package Study in Rural District of Pakistan
We'll reach out to this number within 24 hrs